Eureka Project Is Now Wooing Venture Capital

Paris—The French-inspired Eureka program is hoping to forge links with the world of venture capital to finance a series of cooperative industrial research and development projects throughout Europe. The 2-year-old program features 108 projects involving industrial firms from at least two European countries. Member governments agree to help their own national companies, typically through subsidies, but do not provide direct financial aid. As a consequence, several small and medium-sized com

Written byJacques Richardson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The 2-year-old program features 108 projects involving industrial firms from at least two European countries. Member governments agree to help their own national companies, typically through subsidies, but do not provide direct financial aid. As a consequence, several small and medium-sized companies are finding their finances strained by their involvement in such high-risk fields as biotechnology and robotics. "Eureka is now reaching the stage where outside funding can be involved," Eduardo Months of the Spanish Center for Technological and Industrial Development told a recent meeting in Madrid of the European Venture Capital Association. For some projects, Months said, such outside support is crucial. His comments came on the heels of a study by Britains Cranfield Institute of Technology that criticized Sweden, Denmark and the United Kingdom as being stingy in providing credits to companies involved in Eureka projects.

The idea behind Eureka is to keep science-based industry in the Old ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

Explore synthetic DNA’s many applications in cancer research

Weaving the Fabric of Cancer Research with Synthetic DNA

Twist Bio 
Illustrated plasmids in bright fluorescent colors

Enhancing Elution of Plasmid DNA

cytiva logo
An illustration of green lentiviral particles.

Maximizing Lentivirus Recovery

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery